Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area

Medicine and Dentistry

• Hospital 100%
• Patient with Cancer 100%
• Patient 66%
• Cancer 66%
• Morbidity 33%
• Complication 33%
• Overall Survival 33%
• Immunotherapy 33%
• Patient Population 33%
• Platelet 33%
• Hemoglobin 33%
• Senescence 33%
• Immunosuppressive Drug 33%
• Infection 33%
• Laboratory Assessment 33%
• Vulnerable Population 33%
• Ferritin 33%
• Clinical Assessment 33%
• Dimer 33%
• Lactate Dehydrogenase 33%
• Critical Illness 33%
• Mortality 33%
• Procalcitonin 33%
• Laboratory 33%
• Therapeutic Procedure 33%
• Gender 33%
• Comorbidity 33%
• Cancer Treatment 33%
• Male 33%
• Death 33%
• Systemic Disorder 33%

INIS

• cancer 100%
• patients 100%
• chicago 100%
• hospitals 100%
• metropolitan areas 100%
• covid-19 100%
• laboratories 33%
• populations 33%
• malignancies 33%
• tumors 16%
• assessments 16%
• risks 16%
• medicine 16%
• illinois 16%
• mortality 16%
• inflammation 16%
• death 16%
• immunotherapy 16%
• morbidity 16%
• males 16%
• hemoglobin 16%
• dimers 16%
• ferritin 16%

Immunology and Microbiology

• COVID-19 100%
• Morbidity 33%
• Immunotherapy 33%
• Overall Survival 33%
• Immunosuppressive Drug 33%
• Platelet Count 33%
• Comorbidity 33%
• Ferritin 33%
• Vulnerable Population 33%
• Senescence 33%
• Procalcitonin 33%
• Mortality 33%
• Severe Acute Respiratory Syndrome Coronavirus 2 33%
• Gender 33%